Snowball logo
logo
SAME_logo

Sarana Meditama Metropolitan

SAME JK
Rp292.00-Rp4.00  (1.35%)
Estimate
P/E
231.7
EPS
1.26
Beta
-0.013
Growth
Revenue, YoY
17.65%
Net income, YoY
44.15%
FCF, YoY
123.54%
About the company
Ticker
SAME
ISIN
ID1000126303
Country
Indonesia
Sector (GICS)
Healthcare
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company operates specialty centers. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.

Frequently asked questions

What sector does Sarana Meditama Metropolitan (SAME) operate in?

Sarana Meditama Metropolitan belongs to the Healthcare sector and operates in the Medical Care Facilities industry.

What is Sarana Meditama Metropolitan (SAME) current stock price?

As of the latest data, Sarana Meditama Metropolitan stock price is IDR 292, with a previous close of IDR 296. Sarana Meditama Metropolitan lost -IDR 4 in the last trading session, representing a -1.35% loss.

What is Sarana Meditama Metropolitan (SAME) current market capitalization?

Sarana Meditama Metropolitan market cap is approximately 5.01 trillion.

What is Sarana Meditama Metropolitan (SAME) Earnings Per Share (EPS)?

The trailing EPS is IDR 1.

What is Sarana Meditama Metropolitan (SAME) Price-to-Earnings (P/E) ratio?

Sarana Meditama Metropolitan current P/E ratio is 231.75.

What is Sarana Meditama Metropolitan (SAME) EBITDA?

Sarana Meditama Metropolitan EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 94.76 billion.

Does Sarana Meditama Metropolitan (SAME) pay dividends?

No. Sarana Meditama Metropolitan does not pay a dividend.

What is Sarana Meditama Metropolitan (SAME) beta (volatility) score?

Sarana Meditama Metropolitan has a beta of -0.013, indicating lower volatility than the overall market.